Nosocomial infections after off-pump coronary artery bypass surgery: Frequency, characteristics, and risk factors

Interactive Cardiovascular and Thoracic Surgery

Volumn 6, Issue 6, 2007, Pages 759-767

  Rosmarakis, Evangelos S ^a   Prapas, Sotirios N ^b   Rellos, Konstantinos ^a,b   Michalopoulos, Argyris ^a,b   Samonis, George ^c   Falagas, Matthew E ^a,b,d,e  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b HENRY DUNANT HOSPITAL   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE   (Greece)

Author keywords

C reactive protein; Mortality; Postoperative complications; Predictive value; Procalcitonin; Sternal wound cultures

Indexed keywords

C REACTIVE PROTEIN; CEFTAZIDIME; CEFUROXIME; PROCALCITONIN; TEICOPLANIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; AORTA BALLOON; ARTICLE; BACTEREMIA; CENTRAL VENOUS CATHETERIZATION; COMORBIDITY; EARLY DIAGNOSIS; ERYTHROCYTE TRANSFUSION; FEMALE; HEART LEFT VENTRICLE FAILURE; HORMONE DETERMINATION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDIASTINITIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROLOGIC DISEASE; OFF PUMP CORONARY SURGERY; PNEUMONIA; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; SURGICAL RISK; TREATMENT DURATION; WOUND INFECTION;

BACTEREMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CATHETERIZATION, CENTRAL VENOUS; CORONARY ARTERY BYPASS, OFF-PUMP; CROSS INFECTION; EMERGENCY MEDICAL SERVICES; ERYTHROCYTE TRANSFUSION; HUMANS; INTRA-AORTIC BALLOON PUMPING; LOGISTIC MODELS; MEDIASTINITIS; MOVEMENT DISORDERS; ODDS RATIO; PNEUMONIA; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RISK ASSESSMENT; RISK FACTORS; SURGICAL WOUND INFECTION; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 37349108806     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2007.162511     Document Type: Article

References (15)

1. Falagas ME, Rosmarakis ES, Rellos K, Michalopoulos A, Samonis G, Prapas SN. Microbiologically documented nosocomial infections after coronary artery bypass surgery without cardiopulmonary bypass. J Thorac Cardiovasc Surg 2006;132:481-490.
2. Prapas NS, Anagnostopoulos CE, Kotsis VN, Stavropoulos GP, Sidiropoulos AV, Ananiadou OG, Palatianos GM. A new pattern for using both thoracic arteries to revascularize the entire heart: the π-graft. Ann Thorac Surg 2002;73:1990-1992.
3. Horan TC, Gaynes RP. Surveillance of nosocomial infections. Appendix A: CDC definitions of nosocomial infections. In Mayahall CG (3rd ed): Hospital Epidemiology and Infection Control. Philadelphia: Lippincot Williams and Wilkins 2004:1659-1702.
4. Jaimes F, Garces J, Cuervo J, Ramirez F, Ramirez J, Vargas A, Quintero C, Ochoa J, Tandioy F, Zapata L, Estrada J, Yepes M, Leal H. The systemic inflammatory response syndrome (SIRS) to identify infected patients in the emergency room. Intensive Care Med 2003;29:1368-1371.
5. Michalopoulos A, Geroulanos S, Rosmarakis ES, Falagas ME. Frequency, characteristics, and predictors of microbiologically documented nosocomial infections after cardiac surgery. Eur J Cardiothorac Surg 2006;29:456-460.
6. Fowler VG Jr, O'Brien SM, Muhlbaier LH, Corey GR, Ferguson TB, Peterson ED. Clinical predictors of major infections after cardiac surgery. Circulation 2005;112:I358-365.
7. Michalopoulos A, Nikolaides A, Antzaka C, Deliyanni M, Smirli A, Geroulanos S, Papadimitriou L. Change in anaesthesia practice and postoperative sedation shortens ICU and hospital length of stay following coronary artery bypass surgery. Respir Med 1998;92:1066-1070.
8. Leal-Noval SR, Rincon-Ferrari MD, Garcia-Curiel A, Herruzo-Aviles A, Camacho-Larana P, Garnacho-Montero J, Amaya-Villar R. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest 2001;119:1461-1468.
9. Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004;38:1706-1715.
10. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 1999;56:1839-1888.
11. Baykut D, Schulte-Herbruggen J, Krian A. The value of procalcitonin as an infection marker in cardiac surgery. Eur J Med Res 2000;5:530-536.
12. Meisner M, Rauschmayer C, Schmidt J, Feyrer R, Cesnjevar R, Bredle D, Tschaikowsky K. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med 2002;28:1094-1102.
13. Aouifi A, Piriou V, Bastien O, Blanc P, Bouvier H, Evans R, Celard M, Vandenesch F, Rousson R, Lehot JJ. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med 2000;28:3171-3176.
14. Adamik B, Kubler-Kielb J, Golebiowska B, Gamian A, Kubler A. Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications. Intensive Care Med 2000;26:1259-1267.
15. Boeken U, Feindt P, Micek M, Petzold T, Schulte HD, Gams E. Procalcitonin (PCT) in cardiac surgery: diagnostic value in systemic inflammatory response syndrome (SIRS), sepsis and after heart transplantation (HTX). Cardiovasc Surg 2000;8:550-554.